Klopstock, T. Et Al. 2019. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. LANCET NEUROLOGY , vol.18, no.7 , 631-642.

Klopstock, T., Tricta, F., Neumayr, L., Karin, I., Zorzi, G., Fradette, C., ... Kmiec, T.(2019). Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. LANCET NEUROLOGY , vol.18, no.7, 631-642.

Klopstock, Thomas Et Al. "Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study," LANCET NEUROLOGY , vol.18, no.7, 631-642, 2019

Klopstock, Thomas Et Al. "Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study." LANCET NEUROLOGY , vol.18, no.7, pp.631-642, 2019

Klopstock, T. Et Al. (2019) . "Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study." LANCET NEUROLOGY , vol.18, no.7, pp.631-642.

@article{article, author={Thomas Klopstock Et Al. }, title={Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study}, journal={LANCET NEUROLOGY}, year=2019, pages={631-642} }